Literature DB >> 21503890

Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines.

Ciro Abbondanza1, Caterina De Rosa, Andrea D'Arcangelo, Marianna Pacifico, Clorinda Spizuoco, Giulio Piluso, Erika Di Zazzo, Patrizia Gazzerro, Nicola Medici, Bruno Moncharmont, Giovanni Alfredo Puca.   

Abstract

The retinoblastoma protein-interacting zinc-finger (RIZ) gene, also known as PRDM2, encodes two protein products, RIZ1 and RIZ2, differing for the presence of a 202 aa domain, called PR domain, at the N-terminus of the RIZ1 molecule. While the histone H3 K9 methyltransferase activity of RIZ1 is associated with the negative control of cell proliferation, no information is currently available on either expression regulation of the RIZ2 form or on its biological activity. RIZ proteins act as ER co-activators and promote optimal estrogen response in female reproductive tissues. In estrogen-responsive cells, 17-β estradiol modulates RIZ gene expression producing a shift in the balanced expression of the two forms. Here, we demonstrate that an estrogen-responsive element (ERE) within the RIZ promoter 2 is regulated in a ligand-specific manner by ERα, through both the AF1 and AF2 domains. The pattern of ERα binding, histone H4 acetylation, and histone H3 cyclical methylation of lysine 9 was comparable to other estrogen-regulated promoters. Association of topoisomerase IIβ with the RIZ promoter 2 confirmed the transcriptional activation induced by estrogen. We hypothesize that RIZ2, acting as a negative regulator of RIZ1 function, mediates the proliferative effect of estrogen through regulation of survival and differentiation gene expression.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21503890     DOI: 10.1002/jcp.22803

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 3.  Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?

Authors:  Ewa M Michalak; Jane E Visvader
Journal:  Mol Oncol       Date:  2016-09-23       Impact factor: 6.603

Review 4.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

5.  Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model.

Authors:  Magbubah Essack; Cameron Ross MacPherson; Sebastian Schmeier; Vladimir B Bajic
Journal:  BMC Syst Biol       Date:  2012-10-26

Review 6.  The duality of PRDM proteins: epigenetic and structural perspectives.

Authors:  Federico Di Tullio; Megan Schwarz; Habiba Zorgati; Slim Mzoughi; Ernesto Guccione
Journal:  FEBS J       Date:  2021-05-19       Impact factor: 5.622

7.  Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.

Authors:  Katerina Vrzalikova; Sarah Leonard; Yichao Fan; Andrew Bell; Martina Vockerodt; Patrik Flodr; Kenneth L Wright; Martin Rowe; Qian Tao; Paul G Murray
Journal:  Pathogens       Date:  2012-10-08

8.  Critical Function of PRDM2 in the Neoplastic Growth of Testicular Germ Cell Tumors.

Authors:  Erika Di Zazzo; Carola Porcile; Silvia Bartollino; Bruno Moncharmont
Journal:  Biology (Basel)       Date:  2016-12-14

9.  PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation.

Authors:  Erika Di Zazzo; Caterina De Rosa; Ciro Abbondanza; Bruno Moncharmont
Journal:  Biology (Basel)       Date:  2013-01-14

10.  In vitro interactions between 17β-estradiol and DNA result in formation of the hormone-DNA complexes.

Authors:  Zbynek Heger; Roman Guran; Ondrej Zitka; Miroslava Beklova; Vojtech Adam; Rene Kizek
Journal:  Int J Environ Res Public Health       Date:  2014-07-31       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.